Key points are not available for this paper at this time.
Contraception can be an overlooked aspect of perimenopausal healthcare. While background fertility is low, pregnancies in those aged over 40 years present a higher risk both to the fetus and mother, and have a higher chance of ending in miscarriage or abortion, compared to pregnancies in younger women. This chapter provides a review of key issues related to hormonal contraception in the perimenopause and evaluates each method's effectiveness and safety at a stage of life when venous and cardiovascular disease risks increase. Suitability is assessed considering the person's needs, circumstances and contraindications. Attention is also given to non-contraceptive advantages of certain methods, such as management of perimenopausal symptoms, heavy bleeding and reduction of risks for certain cancers. By highlighting current research and clinical guidelines, this chapter aims to equip healthcare providers with knowledge to support perimenopausal women in making informed reproductive health decisions.
Whitburn et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: